Diverse Women in Clinical Trials
May 2016 | National Resource Center on LGBT
Diverse Women in Clinical Trials Initiative
The U.S. Food and Drug Administration (FDA) Office of Women’s Health launched the Diverse Women in Clinical Trials Initiative in partnership with the National Institutes of Health (NIH) Office of Research on Women’s Health to raise awareness of the importance of the participation of diverse women in clinical trials and to share best practices about clinical study design, recruitment, and data analyses.
SAGE’s National Resource Center on LGBT Aging is working with the FDA Office of Women’s Health to help ensure that women who identify as lesbian, gay, bisexual and transgender (LGBT) are aware of and included in clinical trials.
Clinical trials help to show whether medical tests and treatments work and are safe. Women of all ages, races, ethnicities, sexual orientations, and gender identities as well as women with disabilities and chronic health conditions should consider participating in a clinical trial. Increasing the participation of women from diverse backgrounds in clinical research will require the support and participation of government, industry, clinicians, researchers, and other interested stakeholders.
To learn more, visit http://www.fda.gov/ForConsumers/ByAudience/ForWomen/ucm118508.htm
For more information on research related to sex and gender minorities visit edi.nih.gov/people/sep/lgbti/research/about
For information on older adults and clinical trials visit: https://www.nia.nih.gov/health/publication/clinical-trials-and-older-people